Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
Curing Patients with Cancer, But At What Cost: The Doubleedged Sword of Cancer Therapy --- May the best of what we have done in the past, be the worst of what we will do in the future Louis S. Constine, MD, FASTRO Professor of Radiation Oncology and Pediatrics Cancer Incidence – Distribution by Site SEER Program, 2006 Multiple primary cancers Prostate Breast Lung and bronchus Colon /rectum Urinary bladder Melanomas of the skin Non-Hodgkin lymphoma Uterine corpus Kidney Pancreas Ovary Thyroid Stomach Brain & CNS Multiple myeloma Cervix Esophagus Liver Larynx Hodgkin lymphoma Testis Soft tissue including heart Bone and joint 17.70% 14.60% 12.20% 9.80% 7.90% 3.30% 3.70% 3.50% 2.50% 2.30% 2.10% 1.30% 2.20% 1.30% 1.20% 1.00% 0.70% 0.80% 1.20% 0.60% 0.60% 0.60% 0.50% 0.20% 0 2 Total invasive cancers: 129,552 4 6 8 10 Percent 12 14 16 18 5-Year Survival of Patients with Cancer by Era, SEER, 1975-1998 80 Year of Diagnosis 2004 Projected Survival (%) 70 1993-98 60 1987-92 Peak to Valley Transformation 50 1981-86 1975-80 40 0 10 20 30 40 50 60 Age at Diagnosis (Years) 70 In patients diagnosed with cancer before age 15, the 5-year survival rate improved from 58% in 1975 to 80% in 1997 --- an average annual change of 1.68% Less well known is the remarkable improvement in prolonging survival in adult patients, especially those between 50 and 80 years of age Estimated Number of Cancer Survivors in the United States Over Time 12.1 Million Cancer Survivors United States: 2007 Female Breast 23% Other 17% Prostate 19% Colorectal 10% Gynecologic 9% Lung 3% Melanoma 6% Hematologic 7% Genitourinary 6% Source: http://dccps.nci.nih.gov/ocs/prevalence/prevalence.html. Last accessed Oct. 2009 Cancer Survivorship U.S.: 12 million cancer survivors • 3.5% population • Impact on public health Increases in cancer survival • Earlier diagnosis (screening) • More effective treatment • Prevention of secondary disease • Decreases in mortality from other causes Caring for Cancer Survivors Do you care for survivors in your practice? Always 264 (31.4%) Sometimes 408 (48.6%) Rarely 126 (15.0%) Not at all Do not care for survivors 36 (4.3%) 6 (0.7%) Are you comfortable providing this care? Yes 512 (61.2%) No 213 (25.5%) Do not provide 111 (13.3%) ASCO Prevention Survey, 2004 Essential Elements Of Survivorship Care • Education of the cancer survivor, family, health care providers – Care plan based on future health risks – Promotion of healthy lifestyles – Possible genetic predispositions for counseling • Surveillance for cancer spread, recurrence, or second cancers and for long-term adverse physical, psychosocial, socioeconomic effects • Intervention to prevent or treat consequences of cancer or therapy • Communication between specialists and primary care providers to ensure that the survivor’s health needs are met • Research focused on understanding, preventing, treating adverse consequences of cancer or its therapy • Patient advocacy to address problems related to employment, insurance, and disability Components of Treatment Summary • • • • • Contact information for key individual providers Dates of treatment initiation and completion Diagnostic tests and results Tumor characteristics Therapies provided, including specific agents, title of clinical trials (if any), treatment response, and toxicities experienced • Psychosocial and nutritional services provided • Identification of a coordinator of continuing care Components of Care Plan • • • • • Likely course of recovery from treatment Recommended surveillance Possible long-term effects of treatment and symptoms Possible signs of recurrence and second tumors Possible effects of cancer on daily life (personal relationships, work, mental health) and available resources for support • Potential insurance, employment, and financial consequences of cancer and referrals to counseling, legal aid, and financial assistance if needed Treatment Summary Concordance with IOM Concordance with IOM recommendations N=65 TSs/13 sites (for each domain) No. of sites achieving adequate (≥75%) concordance Descriptive statistics Mean SD Range N (%) Diagnosis 0.46 0.31 0.00–1.00 2 (15.4) Staging and tumor characteristics 0.65 0.35 0.00–1.00 9 (69.2) Surgery 0.73 0.22 0.38–0.98 7 (53.8) Treating physician contact information 0.33 0.30 0.00–0.75 1 (7.7) Clinical trials 0.18 0.25 0.00–0.60 0 (0.0) Chemotherapy 0.52 0.24 0.10–0.83 3 (23.1) Radiotherapy 0.55 0.19 0.26–0.80 2 (15.4) Hormonal therapy 0.79 0.20 0.40–1.00 7 (53.8) Targeted therapy 0.34 0.38 0.00–1.00 3 (23.1) Toxicity 0.52 0.48 0.00–1.00 7 (53.8) Genetic testing 0.26 0.24 0.00–0.60 0 (0.0) Supportive therapy 0.03 0.08 0.00–0.27 0 (0.0) Follow-up care contacts 0.08 0.18 0.00–0.50 0 (0.0) TS Total 0.46 0.19 0.14–0.70 0 (0.0) Survivorship Care Plan concordance with IOM Concordance with IOM recommendations N=65 TSs/13 sites (for each domain) No. of sites achieving adequate (≥75%) concordance Descriptive statistics Mean SD Range N (%) Toxicities and late effects 0.98 0.07 0.75–1.00 13 (100) Breast cancer surveillance 0.82 0.11 0.67–1.00 8 (61.5) Cancer surveillance 0.43 0.35 0.00–1.00 3 (23.1) Non-cancer surveillance 0.77 0.21 0.33–1.00 6 (46.2) Signs of cancer (recurrent and second) 0.32 0.27 0.00–1.00 1 (7.7) Psychosocial effects 0.52 0.35 0.00–0.86 6 (46.2) Referrals and resources 0.62 0.35 0.00–1.00 8 (61.5) Prevention/health promotion 0.46 0.14 0.00–0.50 0 (0.0) Genetic testing recommendations 0.62 0.51 0.00–1.00 8 (61.5) Relatives’ cancer risk 0.01 0.03 0.00–0.10 0 (0.0) SCP total 0.59 0.16 0.37–0.83 2 (15.4) Survivorship Program Components Across Four Health Care Organizations Organization Type Survivorship Program Providers Academic In-person clinical evaluation with Medical oncologist, medical multidisciplinary team nurse practitioner, center psychologist, social worker Community hospital County hospital Primary-care medical group Nurse-led, telephone-based Oncology-certified program; survivors also registered nurse receive mailings and follow- up calls Nurse-practitioner–led clinical Nurse practitioner program; survivors assessed, followed and primary care needs addressed Social worker–led, telephoneLicensed clinical based program; survivors also social worker receive mailings and follow-up calls Partnerships Faculty practice medical group Local physicianowned oncology network In-house Navigation Program Oncology medical groups contracted to provide services to plan members SCP Components Across Four Health Care Organizations Organization Type SCP Completed By Treatment History Components Received By Detailed summary of radiation, chemotherapy, surgeries, hormonal treatment Patient copy, provider copy (PCP, oncologist, ob/gyn, etc), paper chart, and EMR General summary of radiation, chemotherapy, surgeries, hormonal treatment Patient keeps own copy and distributes to oncology care team and primary care Academic medical center Multidisciplinary survivorship team: oncologist, nurse practitioner, psychologist Community hospital Patient, with telephone assistance from survivorship oncology nurse County hospital Survivorship nurse practitioner Detailed summary of radiation, chemotherapy, surgeries, hormonal treatment Patient copy, copy in paper chart, and copy scanned into EMR (electronic template in progress) Primary-care medical group Contracted oncology group physicians and staff, with assistance from survivorship social worker Detailed summary of radiation, chemotherapy, surgeries, hormonal treatment Scanned into EMR (electronic template in progress) and in oncology group paper chart Abbreviations: SCP, survivorship care plan, EMR, electronic medical record; PCP, primary care provider; ob/gyn, obstetrician/gynecologist Survivorship begins at diagnosis! Cancer Diagnosis & Treatment Health & Quality of Life Long-Term Survival What are the physical costs of survivorship? General Considerations • Risk of late effects depends on the tissue and age of patient at time of treatment • Late effects are dose and modality specific (e.g., surgery, radiation, chemotherapy) • Combined modality therapy can have additive risks Tissues at Risk for Late Toxicity • Bone/soft tissues • Immune system • Cardiovascular • Nervous system • Dental • Neuropsychologic • Endocrine • Ophthalmologic • Gastrointestinal • Pulmonary • Hepatic • Renal • Hematological • Reproductive Factors Contributing to Morbidity Host Factors Genetic BRCA, ATM, p53 polymorphisms Age Gender Race Tumor Factors Cancer-Related Morbidity Health Behaviors Tobacco Diet Alcohol Exercise Sun Premorbid Conditions Treatment Factors Aging Histology Site Biology Response Surgery Chemotherapy Radiation therapy Treatment Events Why, a four-year old child could understand this. Someone get me a four-year old child! -- Groucho Marx Radiation therapy is getting complicated Tables and data and lines, oh my... Know Your Cancer-Related Health Risks Surgery for Solid Tumors • After removal of one of paired organs, the remaining organ usually maintains function: – – – – Enucleation (removal of eye) Nephrectomy (removal of kidney) Oophorectomy (removal of ovary) Orchiectomy (removal of testes) • It’s important to take precautions to preserve the health of the remaining organ Know Your Cancer-Related Health Risks Surgery for Solid Tumors • Surgery to remove tumors of bones or soft tissue may affect strength, function, mobility • These surgeries may also cause chronic pain that limits activity • Examples include: – Amputation – Limb-sparing surgery Know Your Cancer-Related Health Risks Chemotherapy for Cancer Prednisone and Methotrexate affect bone strength Anthracyclines (drugs like doxorubicin and daunorubicin) affect heart muscle function Bleomycin, BCNU, CCNU, and busulfan can cause lung scarring Know Your Cancer-Related Health Risks Chemotherapy for Cancer Cisplatin, carboplatin and ifosfamide can affect kidney function Cyclophosphamide can cause injury to the bladder lining Know Your Cancer-Related Health Risks Chemotherapy for Cancer Cisplatin and carboplatin can cause hearing loss Vincristine and cisplatin can affect nerve function Know Your Cancer-Related Health Risks Chemotherapy for Cancer Methotrexate and Cytarabine (Ara C) given by vein or into the spinal fluid can affect learning, concentration and memory Know Your Cancer-Related Health Risks Chemotherapy for Cancer Alkylating agents chemotherapy affects testicular and ovarian function • Risk of injury is related to total dose of medication received • Alkylating agents most often used for childhood cancer: cyclophosphamide, procarbazine, nitrogen mustard, ifosfamide Know Your Cancer-Related Health Risks Radiation for Cancer Brain radiation can affect learning & memory, motor function and sensation Endocrine gland radiation can affect growth, metabolism, and reproduction Know Your Cancer-Related Health Risks Radiation for Cancer Lung scarring from radiation leads to stiff lungs that restrict air flow during breathing Scarring from radiation can affect heart rhythms, heart muscle and valve function and blood vessel flow Know Your Cancer-Related Health Risks Radiation for Cancer Radiation cause kidney damage and bladder scarring Some of the signs of radiation injury of the urinary tract are: • High blood pressure • Blood in urine • Incontinence • Problems voiding Know Your Cancer-Related Health Risks Radiation for Cancer • Decreased testosterone • Decreased, damaged or absent sperm • Damage to duct system to transport sperm • Sexual dysfunction from damage to pelvic nerves Know Your Cancer-Related Health Risks Radiation for Cancer • Decreased estrogen • Damage or depletion of eggs in ovaries • Scarring of lining of the uterus (womb) • Scarring of blood supply to uterus Multiple Primary Cancers Etiologic Factors Cancer #1 Treatment Lifestyle Environment Host factors • • • • • • • • • • • • Tobacco Alcohol Diet Other Contaminants Occupation Viruses Other Cancer #2 Age and gender Genetics Immune function Hormonal, other Modified from Travis LB. Acta Oncologica 2002; 323-333. Interactions and other influences • Gene-environment • Gene-gene Subsequent Malignant Neoplasms DCCPS and DCEG Who is at risk? When to worry? • Age at treatment • Sex/race of survivor • Type/strength of therapy – Chemotherapy – Radiation therapy – Transplant • • • • • Time from treatment Type of cancer History of relapse Family history Health habits Age at Treatment Matters… • Learning problems after brain radiation – Younger patients at higher risk compared to older patients • Infertility after alkylating chemotherapy – Older females at highest risk compared to younger females Chemotherapy Dose Matters… Heart muscle problems after anthracyclines Risk Anthracycline dose Low Less than 100 mg/m2 Medium Between 100 and 300 mg/m2 High More than 300 mg/m2 Combination of Treatments Matters… • Chest radiation: scarring of heart lining, heart valves, or blood vessels • Anthracycline chemotherapy: weakening of the heart muscle Risk of heart problems is greater if cancer treatments have similar risks for health problems. Health habits matter… • Lung scarring can occur after chest radiation and bleomycin • Stiff lungs restrict air flow during breathing • Thick scarred air sacs do not release oxygen to the tissues as well • Smoking increases the risk of lung injury Genes & Family History Matter… Cancer treatment may result in an earlier onset of diseases that “run” in families, especially those that usually present in adulthood • • • • Heart disease High cholesterol High blood pressure Diabetes • • • • Arthritis Osteoporosis Kidney problems Cancer Important Facts About Late Effects • The chances of having late effects after cancer is high • The chance of having serious or life-threatening late effects after modern cancer therapy is low • Knowing your cancer history and possible health risks can help you and your doctor work together to prevent late effects or diagnose health problems early • Regular check-ups are needed to diagnose and prevent late effects What Doctors Can Do… • Design cancer treatments to reduce the risk of late effects • Develop therapies to protect normal tissues • Monitor childhood cancer patients for late effects • Prescribe corrective therapy What Survivors Can Do… • Have regular check-ups so late effects can be prevented or detected in earlier stages • Follow doctor’s advice about medications and other interventions that can reduce the risk of late effects • Practice health behaviors that reduce the risk of late effects Habits that affect risk • Smoking • Sun exposure • Diet • Physical activity • Alcohol intake Tobacco Use • • • • • Don’t smoke. If you do smoke, QUIT! Don’t use any tobacco products Avoid smoke-filled rooms Exercise regularly to keep your lungs fit Check out: 1.877.4SJ.QUIT Preventing Skin Cancer • Do not tan. • When outdoors, stay in the shade. • Limit sun exposure from 10-4. • Practice sun protection measures. – Sunscreen Apply frequently! – Wide brim hat – Long-sleeve shirt – Sun glasses with UV absorption A Healthy Diet • Eat a variety of healthful foods, with an emphasis on plant sources Eat > 5 vegetables and fruits servings each day. Choose whole, rather than processed, grains Limit consumption of red meats Choose foods to maintain a healthful weight • Check out: Physical Activity and Weight • Adopt a physically active lifestyle Moderate activity for > 30 minutes on > 5 days Moderate-to-vigorous activity for > 45 minutes on > 5 days may further reduce breast and colon cancer risks Balance caloric intake with physical activity • Check out: http://www.cdc.gov/healthyweight/ http://www.mypyramidtracker.gov/ Maintain a Healthy Weight • Body mass index Weight (kg) divided by height (cm)2 • Normal weight = BMI 18.5-25 • Overweight = BMI 25-30 • Obese = BMI > 30 Check out: http://www.cdc.gov/healthyweight Alcohol and Health • Alcohol increases risk of cancer of the mouth, throat, voice box, esophagus, liver, and breast • Alcohol may also increase the risk of colon cancer • Alcohol increases risk of liver injury in people with chronic hepatitis and other liver disease • Alcohol may have some benefit in preventing cardiovascular disease Guidelines for Alcohol Intake • If you drink, limit alcohol drinks to less than two drinks a day for men and one for women • A drink is defined as 12 ounces of beer, 5 ounces of wine, or 1.5 ounces of 80 proof distilled spirits Just remember, only one or two! Good Health Habits… • • • • • • Lower cancer risk Lower cardiovascular disease risk Lower bone and muscle problems Improve energy level and mood Improve productivity Lower late effects risks in cancer survivors Specific f/u recommendations for Hodgkin Lymphoma, part 1 • Annual visit to health care provider for prevention and age appropriates screening • Annual physical exam including thyroid and breast exam for women • Consider low dose CT in patients at high risk for lung cancer • Thyroid function tests annually in pts after neck/chest RT Specific f/u recommendations for Hodgkin Lymphoma part 2 • Vaccinations q 6 years in patients after splenectomy • Lipid screening q 1-3 years (LDL <100) • CAD risk factor modification • Women after chest RT treated at age <35 y: – Yearly mammogram 8 years after RT or age 40 – Consider breast MR Specific f/u recommendations for Hodgkin Lymphoma - part 3 • Cardiac work up with EKG, echo, stress test; consider visit with a cardiologist at 10 years • Skin check annually • Baseline vitamin D level • Consider a screening colonoscopy prior to age 50 if prior abdominal radiation We Are Working Hard: »To cure patients with cancer »To minimize late effects And we are making progress!